林克复杂变化是零星和家族性ALS/FTD的标志
bioRxiv : the preprint server for biology
|April 1, 2024
概括
核外LINC复杂变化与肌肉增生侧面硬化症 (ALS) 有关. 这项研究揭示了LINC复杂干扰与ALS神经元中的核异常相关,这表明了新的治疗点.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 遗传学 遗传学是一种遗传学.
背景情况:
- 肌缩侧面硬化症 (ALS) 是一种进展性神经退行性疾病,影响运动神经元,导致肌肉衰弱和失去自愿肌肉控制.
- 核外 (NE),对核结构和功能至关重要,越来越多地涉及到ALS的病变.
- 作为一个关键的NE成分的LINC复合体,将细胞核与细胞骨连接起来,调节核力学和恒温.
研究的目的:
- 研究LINC复合体在ALS病变发生中的作用.
- 检查ALS细胞和动物模型中的LINC复杂变异,特别是那些具有C9ORF72突变的细胞和动物模型.
- 确定LINC复杂功能障碍与ALS中核形态变化之间的相关性.
主要方法:
- 来自C9ORF72突变载体的诱导多能干细胞 (iPSC) 衍生神经元和脊髓器官的分析.
- 从零星ALS和C9-ALS患者的死后脊髓和运动皮质活检的检查.
- 在神经元和组织样本中评估LINC复合体完整性和核形态.
主要成果:
- 在C9ORF72-ALS iPSC衍生的神经元,脊髓器官和死后组织中观察到LINC复合物的广泛变化.
- 这些LINC复杂变化存在于零星和C9-ALS病例中,表明一种保存的病理机制.
- 与ALS神经元中核形态异常显著相关的LINC复合体破坏,独立于TDP-43错位.
结论:
- 林克复合体的形态和功能变化是ALS病原性级联中的重要事件.
- 这种LINC复合体代表了ALS的潜在治疗标.
- 对LINC复杂功能障碍的进一步研究可能会导致ALS的新生物标志物开发.
相关概念视频
Alternative RNA Splicing
21.1K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.1K
Amyloid Fibrils
9.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.5K
Alzheimer's Disease: Overview
469
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
469
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Notch Signaling Pathway
4.3K
The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
4.3K


